What is the long-term trend for Viridian Therapeutics, Inc.'s available for sale investments?

Over 4 years (2021 to 2025), Viridian Therapeutics, Inc.'s available for sale investments has grown at a 35.4% compound annual growth rate (CAGR), from $196.87M to $662.27M.

Viridian Therapeutics, Inc. VRDN Available for sale investments

Available for sale investments at other companies

AmgenAMGN

——

Nektar TherapeuticsNKTR

——

BridgeBio PharmaBBIO

——

BioCryst PharmaceuticalsBCRX

——

Other financials

Income statement

See full

Revenue$141.0K+95.8%

Operating income-$116.2M-23.8%

Net income-$104.9M-20.7%

EPS (diluted)-$1.15-5.5%

Balance sheet

See full

Cash & equivalents$176.3M+51.7%

Total debt$36.8M+59.4%

Total equity$636.0M+5.2%

Total assets$789.0M+19.4%

Cash flow

See full

Operating cash flow-$119.7M-29.1%

CapEx$23.0K-73.3%

Free cash flow-$119.7M-29.0%

Valuation

See full

Market cap$1.91B+82.0%

Enterprise value$1.77B+85.0%

P/S26.9×-3,445×

Profitability

See full

Gross margin36.3%—

Operating margin-543.9%-271pp

Net margin-508.5%-254pp

FCF margin-428.4%-214pp

Returns & leverage

See full

Return on equity-58.1%+7.9pp

Debt / equity0.1×0.0×

Current ratio15.1×-4.3×

Where this comes from

Reported directly by Viridian Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecurities.

The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viridian Therapeutics, Inc.'s available for sale investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Viridian Therapeutics, Inc.'s available for sale investments?: Viridian Therapeutics, Inc. (VRDN) reported available for sale investments of $585.84M in Q1 2026.
How has Viridian Therapeutics, Inc.'s available for sale investments changed year-over-year?: Viridian Therapeutics, Inc.'s available for sale investments decreased by 6.7% year-over-year, from $628.09M to $585.84M.
What is the long-term trend for Viridian Therapeutics, Inc.'s available for sale investments?: Over 4 years (2021 to 2025), Viridian Therapeutics, Inc.'s available for sale investments has grown at a 35.4% compound annual growth rate (CAGR), from $196.87M to $662.27M.